Your session is about to expire
← Back to Search
DVD Program for Smoking (ABLE Trial)
Phase 3
Waitlist Available
Led By Belinda Borrelli, PhD
Research Sponsored by The Miriam Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 and 6 months post-intervention
Awards & highlights
No Placebo-Only Group
Pivotal Trial
Summary
The purpose of this study is to determine if a newly designed DVD program performs better than standard, printed quit-smoking materials to help smokers who have mobility limitations (e.g., use a cane, wheelchair, braces, crutches, prosthesis) to quit smoking.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 and 6 months post-intervention
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 and 6 months post-intervention
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Smoking Status: 7-day and 30-day point prevalence
Secondary study objectives
Behavioral Activation: Goal Setting and Achievement
Behavioral Activation: Pleasant activities
Depressed Mood
+6 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Pivotal Trial
The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: DVD ProgramExperimental Treatment1 Intervention
Group II: Standard Care Printed MaterialsActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
DVD Intervention
2014
N/A
~210
Find a Location
Who is running the clinical trial?
The Miriam HospitalLead Sponsor
244 Previous Clinical Trials
37,318 Total Patients Enrolled
2 Trials studying Smoking
468 Patients Enrolled for Smoking
Belinda Borrelli, PhDPrincipal InvestigatorThe Miriam Hospital
6 Previous Clinical Trials
4,704 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger